MiguelDRegueiroMD
Gastroenterology • Cleveland, OHProfessor and Chief, Digestive Disease Institute, Cleveland Clinic
Dr. Regueiro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Avenue
A2
Cleveland, OH 44195
Summary
- Gastroenterologist specializing in IBD patient-centered care.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 1994 - 1997- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1992 - 1994
Drexel University College of MedicineClass of 1992
Certifications & Licensure
OH State Medical License 1998 - 2026
PA State Medical License 1997 - 2026
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (AGAF) American Gastroenterological Association, 2007
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Evaluating a Shared Decision Making Program for Crohn's Disease Start of enrollment: 2014 Mar 01
- Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 1 citationsMirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study.Miguel Regueiro, Monika Fischer, Peter Bossuyt, Kim McGinnis, Marijana Protic
Inflammatory Bowel Diseases. 2025-02-06 - Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Co..., Bo Shen, Maria T Abreu, Erica R Cohen, Francis A Farraye
Gastrointestinal Endoscopy. 2025-02-01 - Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis.Anita Afzali, Miguel Regueiro, Andres J Yarur, Yamile Zabana, Siew C Ng
United European Gastroenterology Journal. 2025-02-01
Journal Articles
- A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)David A Schwartz, Mahrukh Riaz, Raymond K Cross, Seema A Patil, Sandra M Quezada, Barathi Sivasailam, Sara N Horst, Miguel Regueiro, Leyla Ghazi, Nature
- A Practical Guide to the Safety and Monitoring of New IBD TherapiesMiguel Regueiro, MD, Inflammatory Bowel Diseases
- Correction: ACG Clinical Guideline: Management of Crohn’s Disease in AdultsGary R Lichtenstein, Bruce E Sands, Miguel D Regueiro, Kim L Isaacs, Nature
Authored Content
- Reflecting on a Successful Virtual AIBD 2020 ConferenceDecember 2020
Press Mentions
How Cleveland Clinic Is Advancing IBD Treatment Through Global CollaborationFebruary 4th, 2025- New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UCNovember 26th, 2024
- RSV Vaccination Lowers Risk for IBD Patients over 60, Study FindsOctober 29th, 2024
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
